This research study looks at the adverse effects in studies of psychedelics and MDMA.
Read moreResources for Post-Psychedelic Difficulties
Shared from Ecstatic Integration.
If you’re dealing with post-psychedelic difficulties, here are some resources:
Fireside Project is a phone support service for people experiencing psychedelic or post-psychedelic difficulties.
ICEERS is a plant medicine NGO which has a free support centre.
A university clinic in Berlin which provides free consultations on post-psychedelic difficulties
Cheetah House also offers consultations on post-psychedelic and post-meditation adverse experiences.
The Challenging Psychedelic Experiences Project offers a free online support group for post-psychedelic difficulties on the last Sunday of every month (next one August 25th). We also have research on post-psychedelic difficulties and what helps people cope with them, including a new paper on post-psychedelic existential confusion and ontological shock.
Read moreKetamine Clinics Expected to Explode Over the Next Five Years
The U.S. Ketamine Clinic industry is growing fast.
This is because more people are looking for new ways to treat mental health problems. It’s already a $3.1B industry, but it’s expected to more than double over the next five years.
Read morePsilocybin's Effects on the Brain
Microdosing Psilocybin Continues to Be Popular
A striking 1,250% increase in internet searches related to microdosing has been observed, reflecting a burgeoning curiosity and acceptance.
Read morePsychedelics and Brain Health, Aging
Recent survey results now suggest that psychedelics like LSD, MDMA, and psilocybin may also have protective effects on the brain, potentially countering some aspects of aging.
Read moreDeath Anxiety and Psychedelics
This finding opens new avenues for understanding how these substances can help individuals cope with existential fears.
Read moreLegal and Decriminalized Psychedelics
Here’s an informative article on navigating the legal landscape of psychedelics.
Read moreRisks of Psychedelics
Here’s a great article on the tendency to deny and downplay the harms of psychedelics.
Read moreUC Berkeley’s Groundbreaking Study on Psilocybin
This investigation represents the university’s first human trials involving a Schedule I substance, classified by the federal government as having no accepted medical use.
Psilocybin, commonly known as “shrooms” or “magic mushrooms,” can significantly distort users’ sense of time, mood, and reality, often causing hallucinations.
Read morePsychedelics for Long-COVID Symptoms?
A recent case study has highlighted the potential of using MDMA and psilocybin to manage these persistent symptoms.
Read more